Recursion Pharmaceuticals News

Recursion Pharmaceuticals | DEFA14A: Others

06:17 ET

Recursion Pharmaceuticals | 8-K: Current report

06:07 ET

Recursion Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kinnevik AB(4.3%),Invik S.A.(4.3%)

Nov 4 16:19 ET

Recursion Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.82%)

Nov 4 13:30 ET

Recursion Pharmaceuticals | SCHEDULE 13G/A: Others

Nov 4 09:49 ET

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Oct 31 18:05 ET

Recursion Pharmaceuticals | DEFA14A: Others

Oct 30 17:23 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 29 16:39 ET

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Oct 28 17:29 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 24 16:25 ET

Recursion Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.5%)

Oct 22 15:30 ET

Recursion Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.7%)

Oct 18 11:04 ET

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Oct 17 17:31 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 17 17:16 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 15 16:45 ET

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Oct 10 18:45 ET

Recursion Pharmaceuticals | DEFM14A: Definitive proxy statement relating to merger or acquisition

Oct 10 06:05 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 9 16:27 ET

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 8 16:21 ET

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Oct 4 18:34 ET